gemcitabine (as gemcitamine HCl) 2 GM Injection
- RxCUI
- 1719005
- RxNorm name
- gemcitabine (as gemcitamine HCl) 2 GM Injection
- Display name
- gemcitabine (as gemcitamine HCl) 2 GM Injection
- Full name
- gemcitabine (as gemcitamine HCl) 2 GM Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:13
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | c550dd16-a5e8-44be-87f2-210c15bbb513 | 2024-10-14 | Warnings, Adverse reactions | 1719005 |
| GEMCITABINE | GEMCITABINE | Hospira, Inc. | a625c92b-c569-4b98-8d2e-2b3f5e12b34f | 2024-08-16 | Warnings, Adverse reactions | 1719005 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a625c92b-c569-4b98-8d2e-2b3f5e12b34f | gemcitabine 2 GM Injection [PSN] · gemcitabine 2000 MG Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM Injection [SY] · gemcitabine 2 GM Injection [SY] | 4 | 27 | These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION. GEMCITABINE for injection, for intravenous use Initial U.S. Approval: 1996 | 20240816 |
| c550dd16-a5e8-44be-87f2-210c15bbb513 | gemcitabine 2 GM Injection [PSN] · gemcitabine 2000 MG Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM Injection [SY] · gemcitabine 2 GM Injection [SY] | 4 | 19 | These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION, USP safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION, USP. GEMCITABINE for injection, USP, for intravenous use Initial U.S. Approval:1996 | 20241014 |